Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric H Rubin

Showing results (1-10 of 66) with videos related to

Pageof 7
Sort By:
Contemporary Clinical Trials|December 12, 2022
Adaptive phase 2/3 designs for oncology drug development - Time to hedgeCong Chen, Eric H Rubin
Nature Reviews. Clinical Oncology|February 29, 2012
Drug development and clinical trials--the path to an approved cancer drugEric H Rubin, D Gary Gilliland
Oncogene|October 25, 2003
Mechanisms of resistance to topoisomerase I-targeting drugsZeshaan A Rasheed, Eric H Rubin
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2010
Finding the right dose for cancer therapeutics--can we do better?Eric H Rubin, Keaven M Anderson
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 15, 2004
Epothilones: mechanism of action and biologic activitySusan Goodin, Michael P Kane, Eric H Rubin
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2012
Reports from the 2010 Clinical and Translational Cancer Research Think Tank meeting: design strategies for personalized therapy trialsDonald A Berry, Roy S Herbst, Eric H Rubin
Cancer Discovery|May 16, 2012
The BATTLE trial: a bold step toward improving the efficiency of biomarker-based drug developmentEric H Rubin, Keaven M Anderson, Christine K Gause
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 25, 2010
Introducing new strategies inJames L Abbruzzese, Alexander M M Eggermont, Eric H Rubin
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 3, 2011
Adaptive clinical trial designs for simultaneous testing of matched diagnostics and therapeuticsHoward I Scher, Shelley Fuld Nasso, Eric H Rubin, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 1, 2017
Strategies to Maximize Patient Participation in Clinical TrialsEric H Rubin, Mary J Scroggins, Kirsten B Goldberg, et al.
Pageof 7

Showing results (1-10 of 66) with videos related to

Sort By:
Pageof 7
Contemporary Clinical Trials|December 12, 2022
Adaptive phase 2/3 designs for oncology drug development - Time to hedgeCong Chen, Eric H Rubin
Nature Reviews. Clinical Oncology|February 29, 2012
Drug development and clinical trials--the path to an approved cancer drugEric H Rubin, D Gary Gilliland
Oncogene|October 25, 2003
Mechanisms of resistance to topoisomerase I-targeting drugsZeshaan A Rasheed, Eric H Rubin
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2010
Finding the right dose for cancer therapeutics--can we do better?Eric H Rubin, Keaven M Anderson
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 15, 2004
Epothilones: mechanism of action and biologic activitySusan Goodin, Michael P Kane, Eric H Rubin
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2012
Reports from the 2010 Clinical and Translational Cancer Research Think Tank meeting: design strategies for personalized therapy trialsDonald A Berry, Roy S Herbst, Eric H Rubin
Cancer Discovery|May 16, 2012
The BATTLE trial: a bold step toward improving the efficiency of biomarker-based drug developmentEric H Rubin, Keaven M Anderson, Christine K Gause
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 25, 2010
Introducing new strategies inJames L Abbruzzese, Alexander M M Eggermont, Eric H Rubin
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 3, 2011
Adaptive clinical trial designs for simultaneous testing of matched diagnostics and therapeuticsHoward I Scher, Shelley Fuld Nasso, Eric H Rubin, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 1, 2017
Strategies to Maximize Patient Participation in Clinical TrialsEric H Rubin, Mary J Scroggins, Kirsten B Goldberg, et al.
Pageof 7